Kotak Healthcare Fund Direct Growth
NAV ₹18.847 on 13 November 2026
AMFI name: Kotak Healthcare Fund - Direct Plan - Growth Option · Scheme code 152214 · ISIN INF174KA1PZ7
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY HEALTHCARE INDEX TRI | Category median |
|---|---|---|---|
| 1M | +10.86% | +8.67% | +5.71% |
| 6M | +21.81% | +12.84% | +7.79% |
| 1Y | +34.24% | +38.92% | +4.11% |
| 3Y | - | +28.05% | +14.35% |
| 5Y | - | - | +12.25% |
Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates.
Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.
Risk
From daily NAVs. Alpha, beta and capture are measured against NIFTY HEALTHCARE INDEX TRI.
- Volatility
- 14.72%
- Annualised, 1 year
- Max drawdown
- -18.05%
- Worst fall from a peak, 3 years
- Sharpe ratio
- 1.92
- Return above the risk-free rate per unit of volatility, 1 year
- Sortino ratio
- 1.63
- Like Sharpe, counting only falls, 3 years
- Alpha
- +5.90%
- Return a year beyond what beta explains, 3 years
- Beta
- 0.57
- 1.00 moves in step with the benchmark, 3 years
- Upside capture
- 61%
- Share of the benchmark's rises captured, 3 years
- Downside capture
- 95%
- Share of the benchmark's falls taken (lower is better), 3 years
Rank among peers
Direct plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #- | Kotak Healthcare FundCurrent Fund Kotak Mahindra Mutual Fund | - | +34.24% | 1.92 | 1.03% | ₹743 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 1.03% · Regular 2.54%
- Exit load
- For redemption / switch out within 30 days from the date of allotment: 0.5% If units are redeemed or switched out on or after 30 days from the date of allotment: NIL Units issued on reinvestment of IDCW shall not be subject to entry and exit load. Any exit load charged (net off Goods and Services tax, if any) shall be credited back to the Scheme.
- Fund size (all plans)
- ₹743 CrAverage, quarter to September 2026
- Benchmark
- NIFTY HEALTHCARE INDEX TRI
- Allotment date
- 12 December 2023Scheme document
- Type
- An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
- AMFI scheme code
- 152214
Investment objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
About this fund
Kotak Healthcare Fund Direct Growth is a mutual fund scheme from Kotak Mahindra Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Direct plan with the Growth option. Its NAV was ₹18.847 on 13 November 2026. It returned 34.24% over 1 year, measured from NAVs (3- and 5-year figures are annualised). Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 38.92% over 1 year. Q-Score: 72 out of 100, rated only against funds in the same category. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹743 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.03% a year for the Direct plan. Its scheme summary document gives the allotment date as 12 December 2023.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.